240 related articles for article (PubMed ID: 8220110)
1. Platelet derived growth factor/tyrosine kinase receptor mediated proliferation.
Benito M; Lorenzo M
Growth Regul; 1993 Sep; 3(3):172-9. PubMed ID: 8220110
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of PDGF receptor tyrosine kinase activity from PDGF-mediated inhibition of gap junctional communication.
Pelletier DB; Boynton AL
J Cell Physiol; 1994 Mar; 158(3):427-34. PubMed ID: 8126067
[TBL] [Abstract][Full Text] [Related]
3. The PDGF receptor alpha subunit activates p21ras and triggers DNA synthesis without interacting with rasGAP.
Bazenet CE; Kazlauskas A
Oncogene; 1994 Feb; 9(2):517-25. PubMed ID: 8290262
[TBL] [Abstract][Full Text] [Related]
4. Receptor association and tyrosine phosphorylation of S6 kinases.
Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT
FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565
[TBL] [Abstract][Full Text] [Related]
5. PDGF-independent activation of PDGF-beta receptors in NIH-3T3 cells transformed by c-met protooncogene.
Kochhar KS; Linnekin D; Iyer AP
Exp Cell Res; 1994 Jun; 212(2):414-21. PubMed ID: 7514539
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
7. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
Sachsenmaier C; Sadowski HB; Cooper JA
Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the platelet-derived growth factor-dependent tyrosine kinase activity in sparse and confluent fibroblasts.
Kazlauskas A; DiCorleto PE
J Cell Physiol; 1986 Feb; 126(2):225-36. PubMed ID: 3003124
[TBL] [Abstract][Full Text] [Related]
9. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.
Sorokin A; Reed E; Nnkemere N; Dulin NO; Schlessinger J
Oncogene; 1998 May; 16(19):2425-34. PubMed ID: 9627109
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.
Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Druker BJ; Lydon NB
Cancer Res; 1996 Jan; 56(1):100-4. PubMed ID: 8548747
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor in human glioma.
Westermark B; Heldin CH; Nistér M
Glia; 1995 Nov; 15(3):257-63. PubMed ID: 8586462
[TBL] [Abstract][Full Text] [Related]
12. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
Kovalenko M; Gazit A; Böhmer A; Rorsman C; Rönnstrand L; Heldin CH; Waltenberger J; Böhmer FD; Levitzki A
Cancer Res; 1994 Dec; 54(23):6106-14. PubMed ID: 7954456
[TBL] [Abstract][Full Text] [Related]
13. Compartmentalization of autocrine signal transduction pathways in Sis-transformed NIH 3T3 cells.
Valgeirsdóttir S; Eriksson A; Nistér M; Heldin CH; Westermark B; Claesson-Welsh L
J Biol Chem; 1995 Apr; 270(17):10161-70. PubMed ID: 7730319
[TBL] [Abstract][Full Text] [Related]
14. Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity.
Wang YZ; Wharton W; Garcia R; Kraker A; Jove R; Pledger WJ
Oncogene; 2000 Apr; 19(17):2075-85. PubMed ID: 10815799
[TBL] [Abstract][Full Text] [Related]
15. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
17. Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF.
Lopez-Ilasaca M; Li W; Uren A; Yu JC; Kazlauskas A; Gutkind JS; Heidaran MA
Biochem Biophys Res Commun; 1997 Mar; 232(2):273-7. PubMed ID: 9125162
[TBL] [Abstract][Full Text] [Related]
18. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
19. Pool of ligand-bound platelet-derived growth factor beta-receptors remain activated and tyrosine phosphorylated after internalization.
Sorkin A; Eriksson A; Heldin CH; Westermark B; Claesson-Welsh L
J Cell Physiol; 1993 Aug; 156(2):373-82. PubMed ID: 7688373
[TBL] [Abstract][Full Text] [Related]
20. The sis gene and PDGF.
Williams LT
Cancer Surv; 1986; 5(2):233-41. PubMed ID: 3536086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
